To address this, we hypothesised that key UBD-containing proteins drive LUAD pathogenesis by influencing both tumour cell-intrinsic properties and the tumour immune microenvironment, and that such proteins could serve as novel prognostic biomarkers and therapeutic targets. This evidence concerns the gene UBD and neoplasm.